China and Russia have high clinical volume in paediatric stem cell therapy, though regulatory transparency is limited and outcome verification is challenging. Spain, Portugal, and Germany operate specialised neurodevelopmental centres with published protocols and higher data transparency. South Korea offers paediatric neurodevelopmental programmes with reasonable cost and documented follow-up. For families seeking regulatory accountability and published outcomes, European centres provide more reliable oversight, albeit at higher cost.
Treatments for developmental delay cost €4,500–7,500 per protocol in specialised neurodevelopmental centres. Neurogenic cell therapies command higher costs (€6,500–8,000) due to manufacturing complexity and regulatory oversight. Placental MSC infusions are moderately priced (€4,500–6,000). Most protocols involve 2–4 infusions over 6–12 months. No paediatric insurance scheme reimburses cell therapy for cognitive delay outside experimental frameworks. Families bear full out-of-pocket expense, creating significant access barriers in lower-income regions.
Am I a candidate? → · Developmental Cognitive Delay: full overview → · Developmental Cognitive Delay cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם